𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased risk of acute myeloid leukaemia after treatment for breast cancer

✍ Scribed by R. Renella; H.M. Verkooijen; G. Fioretta; G. Vlastos; J. Kurtz; A.P. Sappino; P. Schäfer; I. Neyroud-Caspar; C. Bouchardy


Book ID
113506763
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
150 KB
Volume
15
Category
Article
ISSN
0960-9776

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Clofarabine in the treatment of poor ris
✍ Janusz Krawczyk; Naeem Ansar; Ronan Swords; Tracy Murphy; Barry MacDonagh; Teres 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract Clofarabine is a second generation nucleoside analogue. It inhibits DNA repair and activates the mitochondrial apoptotic pathway leading to cell death. __In vitro__ clofarabine has demonstrated synergy with daunorubicin and Ara‐C and in phase II clinical trials has shown promising activ

Acute myeloid leukaemia after treatment
✍ Daniele Focosi; Nadia Cecconi; Giuseppe Boni; Enrico Orciuolo; Sara Galimberti; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

## Abstract We report here a patient with relapsed follicular lymphoma who developed secondary acute myeloid leukaemia 15 months after radioimmunotherapy (RIT) with ^90^Y‐ibritumomab tiuxetan, the fifth described case to date. We review the literature for the potential causal relationship between R

No increased risk of breast cancer after
✍ Jesper Lagergren; Weimin Ye; Anders Ekbom 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 45 KB 👁 1 views

An increased risk of breast cancer after cholecystectomy has been proposed, but the results in different studies have not been consistent. To explore this potential association, we conducted a large, population-based, record-linkage, cohort study in Sweden. The cohort consisted of 154,283 women who